Dimitrios H Roukos. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useDrug Resistance, Neoplasm/geneticsHumansIndoles/therapeutic useMelanoma/drug therapyMelanoma/geneticsMutationProtein Kinase Inhibitors/therapeutic useProto-Oncogene Proteins B-raf/geneticsSulfonamides/therapeutic useVemurafenib
Substances: See more » Antineoplastic AgentsIndolesProtein Kinase InhibitorsSulfonamidesVemurafenibBRAF protein, humanProto-Oncogene Proteins B-raf
Year: 2011 PMID: 21417847 DOI: 10.1586/era.11.3
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN: 1473-7140 Impact factor: 4.512